"Carcinoma, Small Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
Descriptor ID |
D018288
|
MeSH Number(s) |
C04.557.470.200.380
|
Concept/Terms |
Carcinoma, Small Cell- Carcinoma, Small Cell
- Carcinomas, Small Cell
- Small Cell Carcinomas
- Oat Cell Carcinoma
- Small Cell Carcinoma
- Carcinoma, Oat Cell
- Carcinomas, Oat Cell
- Oat Cell Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Small Cell".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Small Cell".
This graph shows the total number of publications written about "Carcinoma, Small Cell" by people in this website by year, and whether "Carcinoma, Small Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 3 | 3 | 6 |
1995 | 4 | 2 | 6 |
1996 | 6 | 2 | 8 |
1997 | 5 | 3 | 8 |
1998 | 10 | 5 | 15 |
1999 | 6 | 3 | 9 |
2000 | 8 | 6 | 14 |
2001 | 7 | 6 | 13 |
2002 | 8 | 2 | 10 |
2003 | 11 | 2 | 13 |
2004 | 7 | 2 | 9 |
2005 | 11 | 1 | 12 |
2006 | 10 | 2 | 12 |
2007 | 9 | 3 | 12 |
2008 | 9 | 8 | 17 |
2009 | 2 | 0 | 2 |
2010 | 7 | 2 | 9 |
2011 | 7 | 1 | 8 |
2012 | 2 | 0 | 2 |
2013 | 1 | 1 | 2 |
2014 | 2 | 2 | 4 |
2015 | 3 | 0 | 3 |
2016 | 2 | 1 | 3 |
2017 | 1 | 1 | 2 |
2018 | 4 | 0 | 4 |
2019 | 3 | 0 | 3 |
2020 | 3 | 0 | 3 |
2021 | 2 | 0 | 2 |
2023 | 2 | 0 | 2 |
2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Small Cell" by people in Profiles.
-
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Curr Oncol. 2024 Jun 13; 31(6):3342-3349.
-
CRE24-049: Extrapulmonary Small Cell Carcinoma of Gallbladder Presenting as Acute Cholecystitis. J Natl Compr Canc Netw. 2024 Apr 05; 22(2.5).
-
SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma. Arch Pathol Lab Med. 2023 07 01; 147(7):758-766.
-
Germline pathogenic SMARCA4 variants in neuroblastoma. J Med Genet. 2023 10; 60(10):987-992.
-
Impact of Definitive Local Therapy in Men with Primary Small Cell Prostate Carcinoma. Eur Urol. 2021 09; 80(3):389-390.
-
High-grade Neuroendocrine Carcinomas of the Vulva: A Clinicopathologic Study of 16 Cases. Am J Surg Pathol. 2021 03 01; 45(3):304-316.
-
FDG PET/CT in Diagnosing COVID-19 Infection in a Cancer Patient With Exposure History But Minimal Symptoms. Clin Nucl Med. 2020 Aug; 45(8):656-658.
-
Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract. Gynecol Oncol. 2020 09; 158(3):570-575.
-
A Limited-Versus-Extensive Staging Strategy for Small Cell Prostate Cancer. Am J Clin Oncol. 2020 02; 43(2):87-93.
-
Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears. Am J Clin Pathol. 2019 09 09; 152(4):495-501.